PalmTherapeutics provides PalmReader, a proprietary high‑throughput screening platform that directly measures protein palmitoylation, enabling rapid identification of modulators for this post‑translational modification. The automated, scalable assay can evaluate thousands of compounds per day, integrating seamlessly into existing drug discovery pipelines for pharma, biotech, and academic researchers targeting palmitoylation‑dependent disease pathways.
Funding
$250K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
CFounders
Product
Problem
Current methods for detecting protein palmitoylation are low‑throughput, labor‑intensive, and unsuitable for large‑scale drug discovery, limiting the ability to identify and develop palmitoylation‑modulating therapeutics.
Solution
PalmTherapeutics offers the PalmReader platform, a proprietary high‑throughput screening technology that rapidly detects protein palmitoylation. By automating the assay and scaling it to thousands of samples per run, PalmReader accelerates the identification of novel molecules that modulate palmitoylation. The platform unlocks a previously inaccessible target class, enabling drug discovery programs to pursue therapeutics that act on palmitoylation‑dependent pathways. Data generated by PalmReader can be integrated into standard drug development pipelines to support lead optimization and preclinical testing.
Target Audience
Primary customers are pharmaceutical and biotechnology companies, as well as academic research groups, that are engaged in early‑stage drug discovery targeting palmitoylation‑dependent disease pathways.
Features
- Proprietary screening assay that directly measures protein palmitoylation with high sensitivity
- High‑throughput capability allowing thousands of compounds to be evaluated per day
- Automated workflow reduces manual handling and assay variability
- Scalable format compatible with existing drug discovery infrastructure and data management systems
- Enables rapid identification of both inhibitors and activators of palmitoylation enzymes